GSE125864
Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes
Expression data of primary and metastasic tissues from ALK+ NSCLC patients (Anaplastic lymphoma kinase fusion positive non-small cell lung carcinoma) Overall design: Total RNA from FFPE slides were sequenced using HiSeq 2500